Innovation & Research
Continuous investment in R&D ensures our solutions incorporate the latest advances in medical technology and clinical best practices.
Our Heritage
Built on Clinical Excellence and Engineering Precision
Founded in Amsterdam with a vision to bridge the gap between cutting-edge technology and clinical practice, CedarPro LeafVO has established itself as a trusted partner to healthcare institutions across the European Union. Our multidisciplinary team combines medical device engineering expertise with deep understanding of clinical workflows.
From our state-of-the-art facilities in the Netherlands, we develop and deploy medical technology solutions that address real-world healthcare challenges. Our approach emphasises collaborative partnerships with clinical teams, ensuring every solution delivers measurable improvements in patient outcomes and operational efficiency.
Today, we continue to push the boundaries of medical technology innovation whilst maintaining our commitment to the highest standards of quality, safety, and regulatory compliance that healthcare professionals expect and patients deserve.
15+ years
Healthcare innovation
200+
Clinical partnerships
27 countries
European presence
Our Expertise
Core Competencies in Medical Technology
Our comprehensive capabilities span the entire medical device lifecycle, from initial concept through clinical deployment and ongoing support.
Quality Assurance
Comprehensive quality management systems and regulatory expertise ensuring full compliance with European medical device standards.
Clinical Partnership
Close collaboration with healthcare professionals throughout the development process to ensure solutions meet real clinical needs.
System Integration
Seamless compatibility with existing hospital infrastructure and electronic health record systems for efficient implementation.
European Focus
Deep understanding of European healthcare systems and regulatory requirements across all 27 EU member states.
Outcome-Driven
Evidence-based approach with comprehensive clinical validation and post-market surveillance to demonstrate improved patient outcomes.